Prospective COVID-19 Cohort Study, Dominican Republic
1 other identifier
interventional
1,043
1 country
1
Brief Summary
This project will build on an existing CDC funded cooperative agreement in the Dominican Republic with the Brigham and Women's Hospital (2018-2023) that includes (i) prospective COVID-19 and AFI surveillance at two health facilities and (ii) a nationally representative cross-sectional community-based serological survey of approximately 7,000 healthy adults and children targeting SARS-CoV-2 and other AFI pathogens to be conducted between April and June 2021. This linked study will establish a nested cohort of 2,000 participants enrolled in the national serological survey and prospectively monitor them for COVID-19 symptoms, conduct serial serological testing, implement molecular surveillance for SARS-CoV-2 and sequencing for variants of concern, implement and evaluate WASH mitigation measures, and monitor uptake and perceptions of COVID-19 vaccines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2021
CompletedFirst Posted
Study publicly available on registry
May 24, 2021
CompletedStudy Start
First participant enrolled
August 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2023
CompletedNovember 17, 2025
November 1, 2025
1.3 years
May 19, 2021
November 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Hand hygiene practices
The average daily frequency of study participant hand hygiene events over the previous seven days will be assessed using standardized survey questionnaires at 0-, 3-, 6-, 9-, and 12-months.
1 year
Secondary Outcomes (2)
Acceptability of hand hygiene technology
1 year
SARS-Cov-2 seroconversion
1 year
Study Arms (2)
Alcohol-based hand sanitizer
ACTIVE COMPARATORHalf the study households with receive ABHS through the course of the study
No Alcohol-based hand sanitizer
NO INTERVENTIONHalf the study households with not receive ABHS through the course of the study
Interventions
Provision of ABHS to randomly selected households
Eligibility Criteria
You may qualify if:
- Previously enrolled in a linked national community-based seroepidemiological study in the Dominican Republic
- Agreed and consented to be recontacted to participate in additional research studies at the time of enrollment in #1
- ≥2 years of age
- Agree to participate
You may not qualify if:
- Ward of the State
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Centers for Disease Control and Preventioncollaborator
- London School of Hygiene and Tropical Medicinecollaborator
- The University of Queenslandcollaborator
- Yale Universitycollaborator
- Broad Institute of MIT and Harvardcollaborator
- Ministerio de Salud Publica y Asistencia Social, Republica Dominicanacollaborator
Study Sites (1)
Community study
Santo Domingo, Dominican Republic
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric J Nilles, MD
Brigham and Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 19, 2021
First Posted
May 24, 2021
Study Start
August 18, 2021
Primary Completion
November 22, 2022
Study Completion
February 10, 2023
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
De-identified data for epidemiological analyses and modelling (including demographic data, clinical data, and survey questionnaire survey) will be shared with the following collaborators: Adam Kucharski (LSHTM), Colleen Lau (University of Queensland), Marietta Vasquez (Yale University), Matt Lozier (US CDC), Pardis Sabeti (Broad Institute), and staff at the Health Ministry Division of Epidemiology. Non-identifiable data shared with listed collaborators will be performed with secure file transfer.